Android app Apple app link

Biohaven Pharmaceutical Holding Company Ltd. (BHVN) Analyst Forecast

NYSE Currency in USD Disclaimer
Add to Alerts ADD TO LIST

$20.27

south_east
-$0.1 (-0.49%)
Day's range
$19.84
Day's range
$21.75

Recent Analyst Forecasts and Stock Ratings

Date Brokerage Firm Analyst Name Price Target Price when Posted Upside/Downside
on Report Date		 Details
12/04/2024 RBC Capital Leonid Timashev $61.00 $46.58   30.97%
10/15/2024 Bank of America Securities Jason Gerberry $65.00 $52.77   23.18%
09/24/2024 Leerink Partners Marc Goodman $60.00 $44.22   35.69%
09/24/2024 H.C. Wainwright Douglas Tsao $59.00 $45.94   28.43%
09/24/2024 Bank of America Securities Jason Gerberry $62.00 $45.94   34.96%
09/24/2024 RBC Capital Leonid Timashev $68.00 $45.94   48.02%
09/23/2024 BTIG Thomas Shrader $59.00 $46.56   26.72%
09/23/2024 Robert W. Baird Brian Skorney $60.00 $46.56   28.87%
09/16/2024 Jefferies Amy Li $57.00 $38.08   49.68%
09/04/2024 Tudor Pickering William Pickering $55.00 $38.17   44.09%
07/24/2024 Morgan Stanley Terence Flynn $58.00 $37.81   53.4%
05/29/2024 Robert W. Baird Brian Skorney $58.00 $30.31   91.36%
05/29/2024 RBC Capital Leonid Timashev $59.00 $28.69   105.65%

Biohaven Ltd. FAQ's

Biohaven Ltd. has been rated by research analysts at Deutsche Bank, Bernstein, RBC Capital, Bank of America Securities, Leerink Partners, H.C. Wainwright in the past 90 days.

Premium Content

This content is only available for premium members. Please become a paid member to access.

Download App

Currently, memberships can only be purchased through the app.